Fazila Asmar

1.6k citations
22 papers · 763 indexed · h-index 16
Topics
Lymphoma Diagnosis and Treatment (10 papers)Epigenetics and DNA Methylation (4 papers)Cancer-related gene regulation (4 papers)

In The Last Decade

Fazila Asmar

22 papers receiving 755 citations

Peers

Fazila Asmar
Comparison fields: 5 of 78
  • Molecular Biology 550
  • Pathology and Forensic Medicine 146
  • Cancer Research 131
  • Oncology 116
  • Cellular and Molecular Neuroscience 114
Replace Delphine Bacq with:
Delphine Bacq France
Gerard C. P. Schaafsma Sweden
Sonia Pagliardini Italy
Vidya Mamidipudi United States
Shao-Qing Kuang United States
Huifei Liu United States
María Teresa Calvo Spain
Niklas Ekman Finland
Maurizio Trubia Italy
Angela Russo United States
Fazila Asmar relative to Delphine Bacq France Delphine Bacq's profile →
Citations per field
00.5×1.5×2.4×
Delphine Bacq · 1×
Citations per year

Countries citing papers authored by Fazila Asmar

Since Specialization
Citations

This map shows the geographic impact of Fazila Asmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fazila Asmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fazila Asmar more than expected).

Fields of papers citing papers by Fazila Asmar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fazila Asmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fazila Asmar. The network helps show where Fazila Asmar may publish in the future.

Co-authorship network of co-authors of Fazila Asmar

This figure shows the co-authorship network connecting the top 25 collaborators of Fazila Asmar. A scholar is included among the top collaborators of Fazila Asmar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fazila Asmar. Fazila Asmar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 33
2 27
3 64
4 11
5 14
6 38
7 64
8 16
9 22
10 9
11 20
12 34
13 30
14 103
15 30
16 2
17 1
18 23
19 67
20 121

About Fazila Asmar

Fazila Asmar is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology, having authored 22 papers that have together received 763 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Hematology (109 citations), Cancer Research (131 citations) and Genetics (92 citations). Fazila Asmar has collaborated with scholars based in Denmark, United States and France. Frequent co-authors include Kirsten Grønbæk, Søren G. F. Rasmussen, Ulrik Gether, Frank Guarnieri, Juan Antonio Ballesteros‐Cánovas, Anne D. Jensen, Lasse S. Kristensen, Peter de Nully Brown, Elisabeth Ralfkiær and Jesper Frank Christensen. Their work appears in journals such as Journal of Biological Chemistry, Blood and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026